Chloe Botaine

Chloe Botaine

Biopharmaceutical Research Specialist
Chloe Botaine specializes in biopharmaceutical research and development, offering insights into the latest trends, challenges, and breakthroughs in biopharma. Her content covers topics such as drug discovery, clinical trials, and regulatory affairs. With a focus on advancing science and improving patient care, Chloe’s content contributes to the development of innovative therapies and medicines that address unmet medical needs and improve public health outcomes.
Bridging the Gap Between Health Tracking and Personal Meaning
Digital Health Bridging the Gap Between Health Tracking and Personal Meaning

Relying on digital devices to interpret bodily sensations can lead to an outsourcing of intuition that disconnects individuals from their own physical reality. The modern wearable technology industry, currently valued at roughly $80 billion, has reached a critical stage where biometric accuracy is

Senate Investigates Rising Costs of VA Health Record System
Digital Health Senate Investigates Rising Costs of VA Health Record System

The National Association of VA Physicians and Dentists is urging a total halt to future software expansions due to significant risks to patient safety. This bold stance highlights the growing friction between administrative rollout goals and the clinical reality on the front lines of veteran care.

Drivers of mHealth Adoption for Diabetes Care in China
Digital Health Drivers of mHealth Adoption for Diabetes Care in China

Effort expectancy, defined as the perceived ease of using an interface, stands as the most significant predictor of whether Chinese adults will integrate mobile health tools into their diabetes self-management routines. This realization comes at a pivotal moment as the global healthcare community

Remote Monitoring Cuts Hospitalizations for Peritoneal Dialysis
Digital Health Remote Monitoring Cuts Hospitalizations for Peritoneal Dialysis

While mortality rates for advanced renal disease remain tied to underlying comorbidities, the quality of life and stability of care are profoundly enhanced by real-time digital therapy oversight. The management of end-stage renal disease has transitioned toward home-based solutions, allowing

Can Dual-Layer Edge AI Secure Real-Time Medical IoT?
Patient Care Can Dual-Layer Edge AI Secure Real-Time Medical IoT?

The fusion of security and diagnostics into a single localized pipeline allows healthcare providers to protect patient data and physical well-being simultaneously. In the high-stakes environment of the intensive care unit, where every heartbeat is tracked by a sophisticated web of connected

Can VR and Digital Tools Solve the Addiction Crisis?
Digital Health Can VR and Digital Tools Solve the Addiction Crisis?

The persistent struggle of millions of Americans facing substance use disorders has long highlighted a systemic failure in traditional healthcare delivery models where access to care remains a luxury rather than a standard. Recent statistics indicate that nearly 90% of individuals struggling with

Regulating and Implementing AI Clinical Decision Support
Imaging & Diagnostics Regulating and Implementing AI Clinical Decision Support

The dual-layered protection system created by the FDA and the ONC aims to move AI from opaque black boxes to transparent glass-box clinical tools. This evolution marks a decisive shift in how modern medicine approaches clinical decision support, moving beyond the static constraints of traditional

Can Sweden Overcome Semantic Hurdles in Health Data?
Digital Health Can Sweden Overcome Semantic Hurdles in Health Data?

Nordic collaboration through the eHealth Group highlights that cybersecurity and evidence-based AI treatments are shared priorities that depend on high-quality data interoperability. Sweden currently stands at a decisive moment as it works toward meeting the 2027 requirements set by the European

Can Local Radiologists Accurately Read Alzheimer’s PET Scans?
Imaging & Diagnostics Can Local Radiologists Accurately Read Alzheimer’s PET Scans?

The high level of agreement between local and specialized readers builds a necessary foundation of trust for referring clinicians and patients seeking diagnostic clarity. This finding, recently highlighted in The Journal of Nuclear Medicine, addresses a long-standing concern regarding the

VR Head-Gaze Test Shows Promise for Detecting Early Cognitive Decline
Digital Health VR Head-Gaze Test Shows Promise for Detecting Early Cognitive Decline

A primary concern for digital health tools in older populations is the risk of cybersickness, though recent data indicates these symptoms decrease over time. As the global population continues to age into the late 2020s, finding efficient and accurate ways to identify early signs of memory loss and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later